Evaluation of a Novel Point-of-Care Cryptococcal Antigen Test on Serum, Plasma, and Urine From Patients With HIV-Associated Cryptococcal Meningitis

Monoclonal Antibodies Specific for Immunorecessive Epitopes of Glucuronoxylomannan, the Major Capsular Polysaccharide of Cryptococcus neoformans, Reduce Serotype Bias in an Immunoassay for Cryptococcal Antigen

(2011) Ann Percival et al.   Clinical and Vaccine Immunology

Testing but not treating: missed opportunities and lost lives in the South African antiretroviral therapy programme

(2010) Joseph N Jarvis et al.   AIDS

Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases

(2010) Joseph N Jarvis et al.   BMC INFECTIOUS DISEASES

Cryptococcal Antigen Screening for Patients Initiating Antiretroviral Therapy: Time for Action

(2010) Joseph N. Jarvis et al.   CLINICAL INFECTIOUS DISEASES

Outcomes of cryptococcal meningitis in antiretroviral naïve and experienced patients in South Africa

(2010) Joseph N. Jarvis et al.   JOURNAL OF INFECTION

Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS

(2009) Benjamin J Park et al.   AIDS

Screening for Cryptococcal Antigenemia in Patients Accessing an Antiretroviral Treatment Program in South Africa

(2009) Joseph N. Jarvis et al.   CLINICAL INFECTIOUS DISEASES

Outcomes of Cryptococcal Meningitis in Uganda Before and After the Availability of Highly Active Antiretroviral Therapy

(2008) Andrew Kambugu et al.   CLINICAL INFECTIOUS DISEASES

High‐Dose Amphotericin B with Flucytosine for the Treatment of Cryptococcal Meningitis in HIV‐Infected Patients: A Randomized Trial

(2008) Tihana Bicanic et al.   CLINICAL INFECTIOUS DISEASES

The Use of HAART Is Associated With Decreased Risk of Death During Initial Treatment of Cryptococcal Meningitis in Adults in Botswana

(2008) Gregory P Bisson et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES